Rutgers Study Finds Recent Medicaid Expansions Drastically Improved National Access to Opioid Addiction Medication

Rutgers researchers find recent Medicaid expansions are essential for buprenorphine access as US opioid overdose deaths surpass 80,000 annually.

By: AXL Media

Published: Apr 7, 2026, 6:49 AM EDT

Source: Information for this report was sourced from Rutgers University and JAMA Network Open.

Medicaid Expansion Emerges as Essential Treatment Catalyst

Recent data from Rutgers Health indicates that the expansion of Medicaid insurance coverage has become a primary driver in the distribution of life saving medications for opioid addiction. Investigators found that states adopting expansion between 2017 and 2023 saw substantial population level increases in the dispensing of buprenorphine, a trend that coincides with a period of escalating overdose fatalities. While earlier evaluations of the first wave of Medicaid expansions showed mixed results regarding treatment rates, this new analysis suggests that the current policy landscape has transformed insurance coverage into an indispensable resource for low income Americans struggling with substance use.

Policy Reforms Enhance Effectiveness of Insurance Coverage

The surge in medication uptake is largely attributed to a series of federal and state reforms that have modernized the addiction treatment system. In recent years, legislative changes have authorized expanded outpatient care, integrated the use of telehealth services, and increased the variety of clinicians permitted to prescribe buprenorphine. According to the research team, these shifts created a more flexible environment that allowed Medicaid expansion to have a much broader impact than previously possible. Stephen Crystal, a coauthor of the study, noted that while some old barriers to treatment have been lifted, the role of Medicaid is now more essential than ever for those in need of recovery support.

Addressing the Crisis of Rising Overdose Fatalities

The findings arrive as the United States grapples with a staggering mortality rate, with the Centers for Disease Control and Prevention reporting over 80,000 opioid overdose deaths between October 2023 and September 2024. Because individuals with opioid use disorder are disproportionately represented in low income demographics, the expansion of the joint federal and state program directly targets the most vulnerable populations. By providing free or low cost health coverage to additional residents, the 41 states that have adopted expansion are effectively widening the gateway to evidence based medical interventions during a historic public health emergency.